Andriamandimby S.F., Olive M.M., Shimakawa Y., Rakotomanana F., Razanajatovo I.M., Andrianinarivomanana T.M., Ravalohery J.P., Andriamamonjy S., Rogier C., Héraud J.M.
2017
Background: WHO developed a global strategy to eliminate hepatitis B by 2030 and set target to treat 80% of people with chronic hepatitis B virus (HBV) infection eligible for antiviral treatment. As a first step to achieve this goal, it is essential to conduct a situation analysis that is fundamental to designing national hepatitis plans. We therefore estimated the prevalence of chronic HBV ...
Maladies des animaux; Autres thèmes
2017
Background: WHO developed a global strategy to eliminate hepatitis B by 2030 and set target to treat 80% of people with chronic hepatitis B virus (HBV) infection eligible for antiviral treatment. As a first step to achieve this goal, it is essential to conduct a situation analysis that is fundamental to designing national hepatitis plans. We therefore estimated the prevalence of chronic HBV ...
Maladies des animaux; Autres thèmes